Treatment patterns and real-world clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era

被引：0
|
作者：
Moser, S. Sharman [1 ]
Apter, L. [1 ]
Arunachalam, A. [2 ]
Gazit, S. [3 ]
Chodick, G. [3 ]
Siegelmann-Danieli, N. [4 ]
机构：
[1] Maccabi Inst Res & Innovat Maccabitech, Maccabi Hlth Serv, Tel Aviv, Israel
[2] Merck Res Labs Merck Co Inc, CORE, Rahway, NJ USA
[3] KSM Res & Innovat Ctr, Maccabi Healthcare Serv, Tel Aviv, Israel
[4] Maccabi Hlth Serv, Dept Oncol, Tel Aviv, Israel
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1486P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
    Sacher, Adrian G.
    Le, Lisa W.
    Lau, Anthea
    Earle, Craig C.
    Leighl, Natasha B.
    CANCER, 2015, 121 (15) : 2562 - 2569
  • [2] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [3] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Burgio, M. A.
    Cravero, P.
    Ejzykowicz, F.
    Chandwani, S.
    Delmonte, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada
    Yusuf, Dimas
    Ko, Jenny J.
    Cho, Hyokeun
    Sheremeto, Corey
    Wang, Ying
    Juergens, Rosalyn A.
    Ellis, Peter Michael
    Billawala, Alkarim
    Kay, Amin
    Kulkarni, Swati
    Elfiki, Tarek A.
    Gupta, Rasna
    Naccarato, Krista
    Pennetti, Alex
    Patel, Devalben
    Smith, Elliot Charles
    Walton, Ryan
    Hurry, Manjusha
    Liu, Geoffrey
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [5] Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
    Wu, Yijun
    Yao, Zhuoran
    Zhang, Jianhui
    Han, Chang
    Kang, Kai
    Zhao, Ailin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Real-world study of treatment patterns and clinical outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) post-approval of immunotherapy in the community oncology setting
    Spira, Alexander I.
    Korytowsky, Beata
    Gao, Sara
    Dubois, Renard
    Wilson, Thomas
    Osterland, Andrew
    Shi, Junxin
    Conkling, Paul R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small cell lung cancer
    Hsu, Grace G.
    MacKay, Eric
    Scheuer, Nicolas
    Ramagopalan, Sreeram, V
    IMMUNOTHERAPY, 2021, 13 (18) : 1453 - 1456
  • [8] Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey
    Hollie Bailey
    Adam Lee
    Laura Eccles
    Yong Yuan
    Helen Burlison
    Cameron Forshaw
    Nebibe Varol
    BMC Cancer, 23
  • [9] Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey
    Bailey, Hollie
    Lee, Adam
    Eccles, Laura
    Yuan, Yong
    Burlison, Helen
    Forshaw, Cameron
    Varol, Nebibe
    BMC CANCER, 2023, 23 (01)
  • [10] Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
    Danesi, Valentina
    Massa, Ilaria
    Foca, Flavia
    Delmonte, Angelo
    Crino, Lucio
    Bronte, Giuseppe
    Ragonesi, Maria
    Maltoni, Roberta
    Manunta, Silvia
    Cravero, Paola
    Andrikou, Kalliopi
    Priano, Ilaria
    Balzi, William
    Gentili, Nicola
    Burke, Thomas
    Altini, Mattia
    CANCERS, 2022, 14 (18)
12345